GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Healthcare Corp (AMEX:NHC) » Definitions » 3-Year RORE %

National Healthcare (National Healthcare) 3-Year RORE % : -57.76% (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is National Healthcare 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. National Healthcare's 3-Year RORE % for the quarter that ended in Dec. 2023 was -57.76%.

The industry rank for National Healthcare's 3-Year RORE % or its related term are showing as below:

NHC's 3-Year RORE % is ranked worse than
84.35% of 588 companies
in the Healthcare Providers & Services industry
Industry Median: 1.105 vs NHC: -57.76

National Healthcare 3-Year RORE % Historical Data

The historical data trend for National Healthcare's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Healthcare 3-Year RORE % Chart

National Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.17 -23.67 45.95 -18.83 -57.76

National Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.83 -50.55 -105.17 -84.65 -57.76

Competitive Comparison of National Healthcare's 3-Year RORE %

For the Medical Care Facilities subindustry, National Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Healthcare's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where National Healthcare's 3-Year RORE % falls into.



National Healthcare 3-Year RORE % Calculation

National Healthcare's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 4.33-8.98 )/( 14.76-6.71 )
=-4.65/8.05
=-57.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.


National Healthcare  (AMEX:NHC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


National Healthcare 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of National Healthcare's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


National Healthcare (National Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
100 East Vine Street, Murfreesboro, TN, USA, 37130
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
Executives
Emil E Hassan director
Robert G Adams director, officer: Sr. Vice President & COO P.O. BOX 1398, MURFREESBORO TN 37133-1398
James Paul Abernathy director 2102 GREENLAND DRIVE, MURFREESBORO TN 37130
W Andrew Adams director, officer: CEO P.O. BOX 1398, MURFREESBORO TN 37133-1398
Laroche Richard F Jr director P.O. BOX 1398, MURFREESBORO TN 37133-1398
Burgess Ernest G Iii director P.O. BOX 1398, MURFREESBORO TN 37133-1398
Sandra Y. Trail director 100 VINE STREET, MURFREESBORO TN 37130
Robert Michael Ussery officer: Senior V.P., Operations 100 VINE STREET, SUITE 1400, P. O. BOX 1398, MURFREESBORO TN 37130
Vicki L Dodson officer: Sr.VP Patient Srvcs & CNO 100 VINE STREET, MURFREESBORO TN 37130
Josh A Mccreary officer: Senior VP & General Counsel 100 VINE STREET, MURFREESBORO TN 37130
John K Lines officer: Senior V.P. & General Counsel 601 S. HARBOUR ISLAND BLVD., SUITE 220, TAMPA FL 33602
Jeffrey Russell Smith officer: SVP & Treasurer 100 VINE ST., MURFREESBORO TN 37130
Mcintosh Leroy E. Jr. officer: SVP, Ancillary Services 100 VINE STREET, MURFREESBORO TN 37130
Julia W Powell officer: Sr. V.P., Patient Services 3712 LASCASSAS PIKE, MURFREESBORO TN 37130
Flatt Ben Anderson Sr officer: Senior VP & CIO 100 VINE STREET, MURFREESBORO TN 37130